Skip to content
akaturk Academic measurement
  1. Ana Dal Sağlık Bilimleri Temel Alanı
  2. Yan Dal Farmakoloji
Academic summary YÖKSİS and OpenAlex counted separately.
Articles 32
YÖKSİS32 OpenAlex0
Projects 16
Books 3
Proceedings 46

Citation impact

OpenAlex YÖKSİS articles matched in OpenAlex: 27
h-index 10 Percentile in Türkiye: 85 #28 of 237 at their university by h-index
i10-index
10
Total citations
382
Top 14% in Türkiye
Per article
14.1
FWCI
1.08
1.00 = world average
World top 1%
0
World top 10%
2

h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included.

Field ranking

YÖKSİS ?

Collaboration network

From the author lists of YÖKSİS publication records. Duplicate records of a work count once; institutions are co-authors’ current YÖKSİS affiliations.

Co-authors
44
With an akaturk profile
11
Turkish institutions
2
Co-authored works
%100

Academic co-authors 11

  1. BAHAR TUNÇTAN Profesör · Mersin Üniversitesi 31
  2. MERYEM TEMİZ REŞİTOĞLU Doktor Öğretim Üyesi · Mersin Üniversitesi 20
  3. SEYHAN ŞAHAN FIRAT Profesör · Mersin Üniversitesi 19
  4. TUBA KARA Profesör · Mersin Üniversitesi 3
  5. BAHAR TAŞDELEN Profesör · Mersin Üniversitesi 2
  6. CÜNEYT KEMAL BUHARALIOĞLU Profesör · İzmir Katip Çelebi Üniversitesi 2
  7. DENİZ KİBAR Araştırma Görevlisi · Mersin Üniversitesi 2
  8. SELMA ÜNAL Profesör · Mersin Üniversitesi 2
  9. ŞAKİR NECAT YILMAZ Profesör · Mersin Üniversitesi 2
  10. EYÜP NACİ TİFTİK Profesör · Mersin Üniversitesi 1
Show all (11)
  1. LÜLÜFER TAMER Profesör · Mersin Üniversitesi 1

National collaboration 2 institutions

  1. Mersin Üniversitesi 31 works · 10 academics
  2. İzmir Katip Çelebi Üniversitesi 2 works · 1 academics

Other co-authors (incl. international) 33

DEMET SİNEM GÜDEN YILDIRIM 16AYŞE NİHAL SARI 10KAFAIT ULLAH MALIK 10Ömer Bahçeli 7Dilşah Ezgi Yılmaz 5Muhammed Ahmed-Reda Elosman 5Mehmet Furkan Horat 4Elif İkiz 3JOHN RİCHARD FALCK 3MUSTAFA SERHAN SEVİM 3NEHİR SUCU 3ÖZDEN VEZİR 3Beyza Özgen 2pelin çeçen 2ABDURRAHMAN DOLUNAYAYDAN AKDENİZAYŞEGÜL GÖRÜRAli CağliDemet UnsalFURKAN CEVHERJR FALCKKU MALIKKorkmaz BelmaMAHESH PAUDYALMeltem ÇilMerve BiliktüParinaz Amini DidaniRR ANUGUSEDA KURTZainab SabrieZarife PİREZÜMRÜT KOÇAKÇağla Akıncı Uysal

Authors without an akaturk profile (international researchers, retired or former academics, students, clinicians) are grouped by name spelling; short forms such as “Gulluce M.” join the single full name they match.

Index quartiles

?
Scopus (SJR) 24
  • Q1 2 %8.3
  • Q2 13 %54.2
  • Q3 3 %12.5
  • Q4 6 %25.0
WoS (JCR) 26
  • Q1 3 %11.5
  • Q2 3 %11.5
  • Q3 10 %38.5
  • Q4 10 %38.5
TR Index 3 articles
OpenAlex citation percentile
Top 1%0
Top 10%2
Avg · n 27 %65.0
Other counts

Scopus (SJR)

  • YÖKSİS rows 24

WoS (JCR)

  • YÖKSİS rows 26

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

32articles

Journals with publications

22 journals

Narrow down

Scopus (SJR)
WoS (JCR)
TR Index

Article list

  1. 2026 EFFECTS OF THE UROTENSIN-II RECEPTOR ANTAGONIST SB-710411 ON REMOTE ISCHEMIC PRECONDITIONING IN A RAT MODEL OF LPS-INDUCED ENDOTOXIC SHOCK: CARDIOVASCULAR RESPONSE, INFLAMMATORY INJURY, AND SURVIVAL Shock DOI 10.1097/SHK.0000000000002908 YÖKSİS SJR Q1 JCR Q1 OpenAlex 67.9%
  2. 2025 RIPK1/RIPK3/MLKL Necrosome Contributes to the Sepsis-Induced Cardiorenal Necroptotic Inflammatory Injury and Mortality Current Molecular Pharmacology DOI 10.2174/0118761429374574250415114715 YÖKSİS SJR Q1 JCR Q1 OpenAlex 73.1%
  3. 2025 Inhibition of the RIPK1-driven necroptotic pathway protects against hypotensive and tachycardic responses to LPS in a rat model of septic shock Cellular and Molecular Biology DOI 10.14715/cmb/2025.71.12.8 YÖKSİS SJR Q4 JCR Q4 OpenAlex 61.6%
  4. 2025 Urotensin-II receptor contributes to the pro-inflammatory TLR4/MyD88 NF-κB/iNOS/NO pathway-mediated cardiovascular response to systemic lipopolysaccharide challenge in a septic shock model in rats Cellular and Molecular Biology DOI 10.14715/cmb/2025.71.5.12 YÖKSİS SJR Q4 JCR Q4 OpenAlex 72.9%
  5. 2024 Inhibition of RIPK1-driven necroptosis ameliorates inflammatory hyperalgesia caused by lipopolysaccharide: involvement of TLR-, NLRP3-, and caspase-11- mediated signaling pathways Cellular and Molecular Biology DOI 10.14715/cmb/2024.70.12.7 YÖKSİS SJR Q4 JCR Q4 OpenAlex 84.7%
  6. 2023 Pro-inflammatory GPR75 and anti-apoptotic phospholipase signaling pathways contribute to the ameliorating effect of soluble epoxide hydrolase inhibition on chronic experimental autoimmune encephalomyelitis in mice CMB Association DOI 10.14715/cmb/2023.69.10.2 YÖKSİS SJR Q4 JCR Q4 OpenAlex 65.6%
  7. 2023 NLRX1 ligand, docosahexaenoic acid, ameliorates LPS-induced inflammatory hyperalgesia by decreasing TRAF6/IKK/IκB-α/NF-κB signaling pathway activity CMB Association DOI 10.14715/cmb/2023.69.9.3 YÖKSİS SJR Q4 JCR Q4 OpenAlex 72.2%
  8. 2023 mTOR inhibition modulates apoptosis and oxidative stress in hindlimb ischemia/reperfusion injury Cukurova Medical Journal DOI 10.17826/cumj.13536890 YÖKSİS TR Index JCR Q3
  9. 2023 Pyroptosis and necroptosis inhibitor necrosulfonamide ameliorates lipopolysaccharide-induced inflammatory hyperalgesia in mice Pensoft Publishers DOI 10.3897/pharmacia.70.e108995 YÖKSİS SJR Q2 JCR Q4 OpenAlex 64.1%
  10. 2022 Bexarotene Ameliorates LPS-Induced Hyperalgesia: Contribution of TLR4/MyD88-Dependent Pro-Inflammatory, Anti-Apoptotic and Anti-Inflammatory Signaling Pathways International Journal of Pharmacology DOI 10.3923/ijp.2022.1171.1188 YÖKSİS SJR Q3 JCR Q4 OpenAlex 59.0%
  11. 2022 Activation of GPR75 Signaling Pathway Contributes to the Effect of a 20-HETE Mimetic, 5,14-HEDGE, to Prevent Hypotensive and Tachycardic Responses to Lipopolysaccharide in a Rat Model of Septic Shock. Journal of Cardiovascular Pharmacology DOI 10.1097/FJC.0000000000001265 YÖKSİS SJR Q2 JCR Q3 OpenAlex 78.3%
  12. 2022 Pharmacological Inhibition of Mammalian Target of Rapamycin Attenuates Deoxycorticosterone Acetate Salt\u2013Induced Hypertension and Related Pathophysiology: Regulation of Oxidative Stress, Inflammation, and Cardiovascular Hypertrophy in Male Rats Journal of Cardiovascular Pharmacology DOI 10.1097/FJC.0000000000001187 YÖKSİS SJR Q2 JCR Q3 OpenAlex 79.3%
  13. 2022 Inhibition of mTOR protects against skeletal muscle and kidney injury following hindlimb ischemia-reperfusion in rats by regulating MERK1/ERK1/2 activity. Cukurova Medical Journal DOI 10.17826/cumj.1021518 YÖKSİS TR Index JCR Q3 OpenAlex 2.9%
  14. 2021 Soluble epoxide hydrolase inhibitor trifluoromethoxyphenyl\u20103\u2010(1\u2010propionylpiperidin\u20104\u2010yl)urea prevents hyperalgesia through regulating\n NLRC4\n inflammasome\u2010related pro\u2010inflammatory and anti\u2010inflammatory signaling pathways in the lipopolysaccharide\u2010induced pain mouse model Drug Development Research DOI 10.1002/ddr.21786 YÖKSİS SJR Q3 JCR Q2 OpenAlex 60.9%
  15. 2021 mTOR inhibition as a possible pharmacological target in the management of systemic inflammatory response and associated neuroinflammation by lipopolysaccharide challenge in rats Canadian Journal of Physiology and Pharmacology DOI 10.1139/cjpp-2020-0487 YÖKSİS SJR Q2 JCR Q4 OpenAlex 59.1%
  16. 2021 Suppression of TLR4/MyD88/TAK1/NF-κB/COX-2 Signaling Pathway in the Central Nervous System by Bexarotene, a Selective RXR Agonist, Prevents Hyperalgesia in the Lipopolysaccharide-Induced Pain Mouse Model Neurochemical Research DOI 10.1007/s11064-020-03197-7 YÖKSİS SJR Q2 JCR Q2 OpenAlex 82.8%
  17. 2021 Deneysel Nöroinflamatuvar Hastalık Modelleri: Sistematik Derleme Journal of Literature Pharmacy Sciences DOI 10.5336/pharmsci.2020-79790 YÖKSİS TR Index OpenAlex 47.3%
  18. 2020 Pharmacological inhibition of soluble epoxide hydrolase attenuates chronic experimental autoimmune encephalomyelitis by modulating inflammatory and anti-inflammatory pathways in an inflammasome-dependent and -independent manner. INFLAMMOPHARMACOLOGY YÖKSİS SJR Q2 JCR Q1
  19. 2019 NF-κB activation mediates LPS- or zymosan-induced hypotension and inflammation reversed by BAY61-3606, a selective Syk inhibitor, in rat models of septic and non-septic shock. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY YÖKSİS SJR Q2 JCR Q3
  20. 2019 Eicosanoids derived from cytochrome P450 pathway of arachidonic acid and inflammatory shock PROSTAGLANDINS OTHER LIPID MEDIATORS DOI 10.1016/j.prostaglandins.2019.106377 YÖKSİS SJR Q2 JCR Q3 OpenAlex 79.4%

← Back to academicians